Shehnaaz Suliman, CEO of ReCode Therapeutics, on lipid nanoparticle delivery of genetic medicines.
Information
- Show
- FrequencyUpdated Monthly
- PublishedNovember 8, 2022 at 4:16 AM UTC
- Length1h 10m
- RatingClean
Shehnaaz Suliman, CEO of ReCode Therapeutics, on lipid nanoparticle delivery of genetic medicines.